Regional Director of Sales, East
StrongDMFull Time
Expert & Leadership (9+ years)
Candidates must possess an advanced degree (PhD, PharmD, MS) in health economics, public health, or a related scientific discipline, coupled with a minimum of 7 years of cumulative experience in health economics and outcomes research within the pharmaceutical, biotechnology, or a related environment. A strong publication record in peer-reviewed journals and expertise in formulating and leading innovative HEOR research projects are essential. The role also requires strong verbal and written communication skills, including the ability to present complex concepts persuasively to diverse audiences. Candidates must be based on the East Coast.
The Director of Global HEOR will lead the execution of complex HEOR evidence generation strategies, including cost-effectiveness analysis, budget impact models, observational studies, ITCs, meta-analyses, systematic reviews, and patient-reported outcomes development. They will collaborate with internal HEOR and Market Access teams to implement scientific engagement strategies with external customers like Payers and PBMs. The role involves serving as a resource for delivering clinical and healthcare economic information to formulary decision-makers, proactively communicating product information, and responding to unsolicited customer requests. Additionally, the Director will capture and communicate customer insights, contribute to the design of observational research studies, collaborate with medical communications on publication strategies, and partner with various internal departments to develop and implement HEOR strategies supporting product value.
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.